• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

勘误：EXOSC5作为一种新型预后标志物通过激活ERK和AKT通路促进结直肠癌增殖。

Corrigendum: EXOSC5 as a Novel Prognostic Marker Promotes Proliferation of Colorectal Cancer via Activating the ERK and AKT Pathways.

作者信息

Pan Hongda, Pan Jingxin, Song Shibo, Ji Lei, Lv Hong, Yang Zhangru

机构信息

Department of Gastric Surgery, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, China.

Department of Hematology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China.

出版信息

Front Oncol. 2021 Apr 9;11:670041. doi: 10.3389/fonc.2021.670041. eCollection 2021.

DOI:10.3389/fonc.2021.670041
PMID:33898326
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8063723/
Abstract

[This corrects the article DOI: 10.3389/fonc.2019.00643.].

摘要

[本文更正了文章的数字对象标识符：10.3389/fonc.2019.00643。]

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0176/8063723/aeeae88940dd/fonc-11-670041-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0176/8063723/aeeae88940dd/fonc-11-670041-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0176/8063723/aeeae88940dd/fonc-11-670041-g0002.jpg

相似文献

1
Corrigendum: EXOSC5 as a Novel Prognostic Marker Promotes Proliferation of Colorectal Cancer via Activating the ERK and AKT Pathways.勘误：EXOSC5作为一种新型预后标志物通过激活ERK和AKT通路促进结直肠癌增殖。
Front Oncol. 2021 Apr 9;11:670041. doi: 10.3389/fonc.2021.670041. eCollection 2021.
2
EXOSC5 as a Novel Prognostic Marker Promotes Proliferation of Colorectal Cancer via Activating the ERK and AKT Pathways.EXOSC5作为一种新型预后标志物，通过激活ERK和AKT通路促进结直肠癌增殖。
Front Oncol. 2019 Jul 18;9:643. doi: 10.3389/fonc.2019.00643. eCollection 2019.
3
Corrigendum: Decreased DUSP26 Expression Promotes Malignant Behavior in Glioblastoma Cells Deregulation of MAPK and Akt Signaling Pathway.勘误：DUSP26表达降低促进胶质母细胞瘤细胞的恶性行为及丝裂原活化蛋白激酶（MAPK）和Akt信号通路失调。
Front Oncol. 2021 Apr 12;11:676647. doi: 10.3389/fonc.2021.676647. eCollection 2021.
4
Corrigendum: Polymeric immunoglobulin receptor suppresses colorectal cancer through the AKT-FOXO3/4 axis by downregulating LAMB3 expression.勘误：聚合免疫球蛋白受体通过下调LAMB3表达，经AKT-FOXO3/4轴抑制结直肠癌。
Front Oncol. 2022 Aug 22;12:1012871. doi: 10.3389/fonc.2022.1012871. eCollection 2022.
5
Corrigendum: Berberine and Oligomeric Proanthocyanidins Exhibit Synergistic Efficacy Through Regulation of PI3K-Akt Signaling Pathway in Colorectal Cancer.勘误：小檗碱和原花青素低聚物通过调节PI3K-Akt信号通路在结直肠癌中发挥协同作用。
Front Oncol. 2022 Jun 29;12:952180. doi: 10.3389/fonc.2022.952180. eCollection 2022.
6
Corrigendum: Targeting ACLY Attenuates Tumor Growth and Acquired Cisplatin Resistance in Ovarian Cancer by Inhibiting the PI3K-AKT Pathway and Activating the AMPK-ROS Pathway.勘误：靶向ACLY通过抑制PI3K-AKT途径和激活AMPK-ROS途径减弱卵巢癌中的肿瘤生长和获得性顺铂耐药性。
Front Oncol. 2021 Sep 7;11:742374. doi: 10.3389/fonc.2021.742374. eCollection 2021.
7
Corrigendum: The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma.勘误：LRIG3和可溶性LRIG3在胶质母细胞瘤中的预后及治疗潜力
Front Oncol. 2020 Sep 25;10:591112. doi: 10.3389/fonc.2020.591112. eCollection 2020.
8
Corrigendum: ITGB5 promotes innate radiation resistance in pancreatic adenocarcinoma by promoting DNA damage repair and the MEK/ERK signaling pathway.勘误：整合素β5（ITGB5）通过促进DNA损伤修复和MEK/ERK信号通路，增强胰腺腺癌的固有辐射抗性。
Front Oncol. 2024 Feb 22;14:1381151. doi: 10.3389/fonc.2024.1381151. eCollection 2024.
9
Corrigendum: CORO1C is Associated with Poor Prognosis and Promotes Metastasis Through PI3K/AKT Pathway in Colorectal Cancer.勘误：CORO1C与结直肠癌预后不良相关，并通过PI3K/AKT途径促进转移。
Front Mol Biosci. 2021 Aug 30;8:727347. doi: 10.3389/fmolb.2021.727347. eCollection 2021.
10
Corrigendum: Differential Expression Analysis Revealing CLCA1 to Be a Prognostic and Diagnostic Biomarker for Colorectal Cancer.勘误：差异表达分析揭示CLCA1是结直肠癌的一种预后和诊断生物标志物。
Front Oncol. 2020 Dec 18;10:634122. doi: 10.3389/fonc.2020.634122. eCollection 2020.